EGFR and non-small cell lung carcinoma: Some cell surface receptors such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and receptor of silencing 1 (ROS1) are overactive in the pathology of NSCLC [6,7].